6550--Covid Reagents and Supplies
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C26226Q0433
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- See Sow
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 is soliciting quotations for COVID-19 reagents and diagnostic test supplies, specifically Cepheid GenXpert and Infinity Instrumentation-compatible molecular diagnostic kits and consumables. The solicitation (36C26226Q0433) targets in-vitro diagnostic substance manufacturers with a size standard of 1,250 employees under NAICS code 325413. Key contract requirements include supplying reagents and consumables on a cost-per-test basis for 16 molecular infectious disease and oncology assays, providing service and maintenance for 11 GenXpert systems with Cepheid-trained and certified technicians, and ensuring all contractor employees undergo VA background investigations with favorable adjudication within 30 days of award. Evaluation will be based on technical capability to meet minimum requirements, price competitiveness, and compliance with salient physical and functional characteristics on a brand name or equal basis. Offerors must submit questions by March 6, 2026, with quotation responses due by March 13, 2026 at 9:00 AM Pacific Time to Contract Specialist Carlos Magana, and prices must remain firm for 120 calendar days from offer receipt.
This solicitation has no set-aside designation and will be awarded as a firm-fixed price contract through full and open competition to a single firm. The procurement encompasses approximately 5,020 units of various diagnostic kits and collection devices, including BCR-ABL kits, C. difficile assays, CT/NG kits, MRSA NXG kits, and respiratory panels (SARS-CoV-2, Flu A/B, RSV), among others, with service coverage including unlimited Monday-through-Friday visits, 24/7 phone support, preventive maintenance, and emergency repairs within 24 hours. The contract period runs from March 13, 2026 through September 12, 2026, with delivery to eight VA healthcare facilities across California, Arizona, and New Mexico under FOB Destination terms with all shipping costs included in quoted prices. The place of performance is centered at 180 Montgomery Street, San Francisco, California 94104, with service delivery required to facilities including VA Greater Los Angeles, VA Long Beach, VA Loma Linda, VA San Diego, VA New Mexico, VA Northern Arizona, VA Southern Arizona, and VA Phoenix Healthcare Systems.
Notice text
***View attachments for details***
Files
| File | Type | Posted |
|---|---|---|
| AttachmentB- SOW .pdf | ||
| Attachment A.xlsx | XLSX spreadsheet | |
| 36C26226Q0433.docx | DOCX document | |
| RFQ doc.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Reagents | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity